• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期银屑病关节炎的诊断与干预

Diagnosis and Intervention in Early Psoriatic Arthritis.

作者信息

Hioki Tomoyuki, Komine Mayumi, Ohtsuki Mamitaro

机构信息

Department of Dermatology, Central Japan International Medical Center, Minokamo 505-8510, Japan.

Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Japan.

出版信息

J Clin Med. 2022 Apr 6;11(7):2051. doi: 10.3390/jcm11072051.

DOI:10.3390/jcm11072051
PMID:35407659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8999837/
Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory disorder that affects approximately 20-30% of patients with psoriasis. PsA causes deformities and joint damage, impairing quality of life and causing long-term functional disability. Several recent studies demonstrated that early diagnosis and intervention for PsA prevents permanent invalidity. However, the clinical features of PsA vary and are shared with other differential diseases, such as reactive arthritis, osteoarthritis, and ankylosing spondylitis. The common and overlapping features among these diseases complicate the accurate early diagnosis and intervention of PsA. Therefore, this review focuses on the current knowledge of the diagnosis of early PsA and discusses the meaning of early intervention for early PsA.

摘要

银屑病关节炎(PsA)是一种慢性炎症性疾病,影响约20%-30%的银屑病患者。PsA会导致畸形和关节损伤,损害生活质量并造成长期功能残疾。最近的几项研究表明,对PsA进行早期诊断和干预可预防永久性残疾。然而,PsA的临床特征各不相同,且与其他鉴别疾病(如反应性关节炎、骨关节炎和强直性脊柱炎)有共同之处。这些疾病之间常见且重叠的特征使PsA的准确早期诊断和干预变得复杂。因此,本综述重点关注早期PsA诊断的当前知识,并讨论早期干预对早期PsA的意义。

相似文献

1
Diagnosis and Intervention in Early Psoriatic Arthritis.早期银屑病关节炎的诊断与干预
J Clin Med. 2022 Apr 6;11(7):2051. doi: 10.3390/jcm11072051.
2
Psoriatic arthritis for dermatologists.皮肤科医生须知的银屑病关节炎
J Dermatolog Treat. 2020 Nov;31(7):662-679. doi: 10.1080/09546634.2019.1605142. Epub 2019 May 7.
3
Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires.韩国银屑病患者银屑病关节炎的临床特征:一项使用银屑病关节炎筛查问卷对196例银屑病患者进行的横断面观察研究。
Rheumatol Int. 2016 Feb;36(2):207-12. doi: 10.1007/s00296-015-3365-3. Epub 2015 Sep 22.
4
Clinical features of psoriatic arthritis.银屑病关节炎的临床特征。
Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101670. doi: 10.1016/j.berh.2021.101670. Epub 2021 Mar 17.
5
Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.2009例银屑病患者中银屑病关节炎及关节症状的患病率和临床特征:一项德国全国性调查结果
J Eur Acad Dermatol Venereol. 2009 Jun;23(6):683-91. doi: 10.1111/j.1468-3083.2009.03159.x. Epub 2009 Mar 6.
6
Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.银屑病关节炎与骨关节炎和类风湿关节炎的鉴别:高级执业医师的叙述性综述与指南
Rheumatol Ther. 2021 Dec;8(4):1493-1517. doi: 10.1007/s40744-021-00365-1. Epub 2021 Sep 14.
7
Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire.使用银屑病关节炎筛查评估问卷对韩国银屑病患者进行银屑病关节炎筛查
Ann Dermatol. 2015 Jun;27(3):265-8. doi: 10.5021/ad.2015.27.3.265. Epub 2015 May 29.
8
Psoriatic arthritis.银屑病关节炎。
J Dermatol. 2021 Jun;48(6):741-749. doi: 10.1111/1346-8138.15954.
9
The other arthritides. Roentgenologic features of osteoarthritis, erosive osteoarthritis, ankylosing spondylitis, psoriatic arthritis, Reiter's disease, multicentric reticulohistiocytosis, and progressive systemic sclerosis.其他关节炎。骨关节炎、侵蚀性骨关节炎、强直性脊柱炎、银屑病关节炎、赖特综合征、多中心网状组织细胞增多症及进行性系统性硬化症的放射学特征。
Radiol Clin North Am. 1988 Nov;26(6):1195-212.
10
[Medical care situation of patients with ankylosing spondylitis and psoriatic arthritis in Germany : Medical care situation of patients with spondyloarthritis (SpA): ankylosing spondylitis (AS) and psoriatic arthritis (PsA) from the perspective of rheumatologists in private practice and hospitals in Germany-Results of the research project "SpA Loop-Life of Outpatients"].德国强直性脊柱炎和银屑病关节炎患者的医疗状况:脊柱关节炎(SpA)患者的医疗状况:从德国私人诊所和医院的风湿病学家角度看强直性脊柱炎(AS)和银屑病关节炎(PsA)——“SpA Loop - 门诊患者生活”研究项目的结果
Z Rheumatol. 2019 May;78(4):372-381. doi: 10.1007/s00393-019-0619-6.

引用本文的文献

1
Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis.全身免疫炎症指数作为自身免疫性疾病中的一种通用生物标志物:来自类风湿关节炎、狼疮和脊柱关节炎的见解
Front Immunol. 2025 Aug 7;16:1621209. doi: 10.3389/fimmu.2025.1621209. eCollection 2025.
2
Balancing efficacy and hepatotoxicity: a comprehensive review of oral medications in psoriasis management.平衡疗效与肝毒性:银屑病治疗中口服药物的综合综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 25. doi: 10.1007/s00210-025-04334-1.
3
Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

本文引用的文献

1
Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis.银屑病关节炎的早期起源:从银屑病进展至银屑病关节炎的临床、遗传及分子生物标志物
Front Med (Lausanne). 2021 Aug 18;8:723944. doi: 10.3389/fmed.2021.723944. eCollection 2021.
2
Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.治疗银屑病患者的皮肤用生物制剂可降低银屑病关节炎的发生率。
Ann Rheum Dis. 2022 Jan;81(1):74-79. doi: 10.1136/annrheumdis-2021-220865. Epub 2021 Jul 19.
3
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis.
改善病情抗风湿药物治疗延迟对银屑病关节炎的影响:CorEvitas银屑病关节炎/脊柱关节炎注册研究
ACR Open Rheumatol. 2025 Jun;7(6):e70019. doi: 10.1002/acr2.70019.
4
Can Circulating MicroRNAs, Cytokines, and Adipokines Help to Differentiate Psoriatic Arthritis from Erosive Osteoarthritis of the Hand? A Case-Control Study.循环微RNA、细胞因子和脂肪因子能否有助于鉴别银屑病关节炎与手部侵蚀性骨关节炎?一项病例对照研究。
Int J Mol Sci. 2025 May 12;26(10):4621. doi: 10.3390/ijms26104621.
5
sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: a systematic review and meta-analysis with meta-regression.可溶性CD40和可溶性CD40配体作为风湿性疾病的候选生物标志物:一项采用Meta回归的系统评价和Meta分析
Front Immunol. 2025 Mar 19;16:1479904. doi: 10.3389/fimmu.2025.1479904. eCollection 2025.
6
Analysis of PEST Questionnaire Responses in Patients with Psoriasis in Daily Practice: Results from a Single-Center of Psoriasis in the Czech Republic.日常实践中银屑病患者PEST问卷回复分析:来自捷克共和国单中心银屑病研究的结果
Dermatol Ther (Heidelb). 2025 Apr;15(4):819-829. doi: 10.1007/s13555-025-01374-6. Epub 2025 Mar 3.
7
Refractory psoriatic arthritis: emerging concepts in whole process management.难治性银屑病关节炎:全程管理中的新观念
Clin Rheumatol. 2025 Feb;44(2):583-590. doi: 10.1007/s10067-024-07267-x. Epub 2025 Jan 14.
8
A systematic review and meta-analysis of the endothelial-immune candidate biomarker endoglin in rheumatic diseases.系统性综述和荟萃分析:风湿性疾病中内皮-免疫候选生物标志物内脂素。
Clin Exp Med. 2024 Nov 13;25(1):4. doi: 10.1007/s10238-024-01519-5.
9
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.司库奇尤单抗治疗银屑病:关于早期治疗及真实世界证据的叙述性综述
Dermatol Ther (Heidelb). 2024 Oct;14(10):2739-2757. doi: 10.1007/s13555-024-01255-4. Epub 2024 Sep 24.
10
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review.治疗银屑病关节炎的成本及成本效益:一项更新的系统文献回顾。
Pharmacoeconomics. 2024 Dec;42(12):1329-1343. doi: 10.1007/s40273-024-01428-1. Epub 2024 Aug 24.
JAK 抑制剂与银屑病关节炎:系统评价和荟萃分析。
Autoimmun Rev. 2021 Oct;20(10):102902. doi: 10.1016/j.autrev.2021.102902. Epub 2021 Jul 15.
4
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.GRAPPA 治疗推荐:2020 年 GRAPPA 年会更新。
J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681.
5
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study.用于研究的银屑病关节炎临床前期阶段的共识术语:德尔菲共识研究结果
Nat Rev Rheumatol. 2021 Apr;17(4):238-243. doi: 10.1038/s41584-021-00578-2. Epub 2021 Feb 15.
6
Psoriasis: Recent progress in molecular-targeted therapies.银屑病:分子靶向治疗的最新进展。
J Dermatol. 2021 Jun;48(6):761-777. doi: 10.1111/1346-8138.15727. Epub 2021 Jan 6.
7
Innovative Imaging Technique for Visualization of Vascularization and Established Methods for Detection of Musculoskeletal Inflammation in Psoriasis Patients.用于可视化血管生成的创新成像技术及银屑病患者肌肉骨骼炎症检测的既定方法。
Front Med (Lausanne). 2020 Sep 2;7:468. doi: 10.3389/fmed.2020.00468. eCollection 2020.
8
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.EULAR 推荐的药物治疗银屑病关节炎管理:2019 年更新。
Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159.
9
Pathogenesis of Psoriatic Arthritis.银屑病关节炎的发病机制。
Crit Rev Immunol. 2019;39(5):361-377. doi: 10.1615/CritRevImmunol.2020033243.
10
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention.从银屑病到银屑病关节炎:影像学在向银屑病关节炎转变中的见解及对关节炎预防的意义。
Curr Rheumatol Rep. 2020 May 16;22(6):24. doi: 10.1007/s11926-020-00891-x.